Sfoglia per Rivista  VACCINE

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 12 a 31 di 65
Titolo Data di pubblicazione Autore(i) File
Effectiveness of email-based reminders to increase vaccine uptake: a systematic review 1-gen-2020 Frascella, Beatrice; Oradini-Alacreu, Aurea; Balzarini, Federica; Signorelli, Carlo; Lopalco, Pier Luigi; Odone, Anna
Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households 1-gen-2003 Esposito, Susanna Maria Roberta; P., Marchisio; R., Cavagna; S., Gironi; S., Bosis; L., Lambertini; R., Droghetti; N., Principi
Efficacy of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell mediated immunity 1-gen-2009 Martelli, Paolo; Gozio, S; Ferrari, Luca; Rosina, S; DE ANGELIS, Elena; Quintavalla, Cecilia; Bottarelli, E; Borghetti, Paolo
Efficient heterologous antigen gene delivery and expression by a replication-attenuated BoHV-4-based vaccine vector 1-gen-2013 Capocefalo, Antonio; Carlo, Mangia; Franceschi, Valentina; Jacca, Sarah; Vicky L., van Santen; Donofrio, Gaetano
Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010 1-gen-2012 T., Seyler; A., Bella; S., Puzelli; Donatelli, I; C., Rizzo; M. C., Rota; F., D’Ancona; S., Giannitelli; A., Pavan; L., Macchi; M., Gramegna; A., Zanetti; A. C., Finarelli; M. G., Pascucci; G., Frasca; L., Moschella; V., Sambri; Tanzi, Maria Luisa; P., Macini
Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children 1-gen-2009 Esposito, S.; Pelucchi, C.; Tel, F.; Chiarelli, G.; Sabatini, C.; Semino, M.; Marseglia, G. L.; De Mattia, D.; Principi, N.
Herpes zoster prevention: A difficult problem to solve 1-gen-2018 Esposito, Susanna; Principi, Nicola
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule 1-gen-2013 Rodgers, G. L.; Esposito, S.; Principi, N.; Gutierrez-Brito, M.; Diez-Domingo, J.; Pollard, A. J.; Snape, M. D.; Martinón-Torres, F.; Gruber, W. C.; Patterson, S.; Thompson, A.; Gurtman, A.; Paradiso, P.; Scott, D. A.
Immunization of bighorn sheep against Mannheimia haemolytica with a bovine herpesvirus 1-vectored vaccine 1-gen-2017 Batra, Sai A.; Shanthalingam, Sudarvili; Donofrio, Gaetano; Haldorson, Gary J.; Chowdhury, Shafiqul; White, Stephen N.; Srikumaran, Subramaniam
Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen. 1-gen-2011 Franceschi, Valentina; Capocefalo, Antonio; Calvo Pinilla, E; Redaelli, M; Mucignat Caretta, C; Mertens, P; Ortego, J; Donofrio, Gaetano
The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy 1-gen-2016 Durando, P.; Esposito, S.; Bona, G.; Cuccia, M.; Desole, M. G.; Ferrera, G.; Gabutti, G.; Pellegrino, A.; Salvini, F.; Henry, O.; Povey, M.; Marchetti, F.
Immunogenicity and safety of intradermal influenza vaccine in children 1-gen-2011 Esposito, Susanna Maria Roberta; C., Daleno; I., Picciolli; L., Tagliaferri; A., Scala; G., Prunotto; V., Montinaro; C., Galeone; N., Principi
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine 1-gen-2009 Y., Gillet; G. C., Steri; U., Behre; J. P., Arsène; X., Lanse; K., Helm; Esposito, Susanna Maria Roberta; N., Meister; M. G., Desole; M., Douha; P., Willems
Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants 1-gen-2005 Esposito, S.; Pugni, L.; Bosis, A.; Proto, A.; Cesati, L.; Bianchi, C.; Cimino, C.; Mosca, F.; Principi, N.
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children 1-gen-2016 Esposito, S.; Giavoli, C.; Trombetta, C.; Bianchini, S.; Montinaro, V.; Spada, A.; Montomoli, E.; Principi, N.
Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants 1-gen-2007 Esposito, Susanna Maria Roberta; B., Corbellini; S., Bosis; L., Pugni; E., Tremolati; C., Tagliabue; D., Toneatto; F., Mosca; N., Principi
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis 1-gen-2012 L., Dell'Era; F., Corona; C., Daleno; A., Scala; N., Principi; Esposito, Susanna Maria Roberta
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major 1-gen-2010 Esposito, Susanna Maria Roberta; E., D'Angelo; C., Daleno; F., Peia; A., Scala; D., Serra; N., Mirra; C., Galeone; N., Principi
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union 1-gen-2020 Calzetta, L.; Pistocchini, E.; Ritondo, B. L.; Roncada, P.; Palma, E.; di Cave, D.; Mattei, M.; Britti, D.
Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection 1-gen-2014 Esposito, Susanna Maria Roberta; P., Marchisio; E., Prada; C., Daleno; L., Porretti; R., Carsetti; A., Bosco; V., Ierardi; A., Scala; N., Principi
Mostrati risultati da 12 a 31 di 65
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile